In 2000, genetic analysis of families with PAH identified heterozygous germline mutations in BMPR2, the gene encoding bone morphogenetic protein receptor type 2, a member of the transforming growth factor-β superfamily4. Here, BMPR2 is linked to pulmonary arterial hypertension.